Literature DB >> 21367615

In vitro toxicity testing of zinc tetrasulfophthalocyanines in fibroblast and keratinocyte cells for the treatment of melanoma cancer by photodynamic therapy.

K Maduray1, A Karsten, B Odhav, T Nyokong.   

Abstract

A series of water-soluble tetrasulfonated metallophthalocyanines (MPcs) dyes have been studied to be used as a drug or photosensitizer (PS) in photodynamic therapy (PDT) for the treatment of cancers. During PDT the PS is administrated intravenously or topically to the patient before laser light at an appropriate wavelength is applied to the cancerous area to activate the PS. The activated PS will react with oxygen typically present in the cancerous tissue to generate reactive oxygen species for the destruction of the cancerous tissue. This in vitro study aimed at investigating the cytotoxic effects of different concentrations of zinc tetrasulfophthalocyanines (ZnTSPc) activated with a diode laser (λ = 672 nm) on melanoma, keratinocyte and fibroblast cells. To perform this study 3 × 10⁴ cells/ml were seeded in 24-well plates and allowed to attach overnight, after which cells were treated with different concentrations of ZnTSPc. After 2h, cells were irradiated with a constant light dose of 4.5J/cm². Post-irradiated cells were incubated for 24 h before cell viability was measured using the CellTiter-Blue Viability Assay. Data indicated high concentrations of ZnTSPc (60-100 μg/ml) in its inactive state are cytotoxic to the melanoma cancer cells. Also, results showed that photoactivated ZnTSPc (50 μg/ml) was able to reduce the cell viability of melanoma, fibroblast and keratinocyte cells to 61%, 81% and 83% respectively. At this photosensitizing concentration the efficacy the treatment light dose of 4.5J/cm² against other light doses of 2.5J/cm², 7.5J/cm² and 10J/cm² on the different cell lines were analyzed. ZnTSPc at a concentration of 50 μg/ml activated with a light dose of 4.5J/cm² was the most efficient for the killing of melanoma cancer cells with reduced killing effects on healthy normal skin cells in comparison to the other treatment light doses. Melanoma cancer cells after PDT with a photosensitizing concentration of 50μg/ml and a treatment light dose of 4.5J/cm² showed certain apoptosis characteristics such as chromatin condensation and fragmentation of the nucleus. This concludes that low concentrations of ZnTSPc activated with the appropriate light dose can be used to induce cell death in melanoma cells with the occurrence of minimal damage to surrounding healthy tissue.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367615     DOI: 10.1016/j.jphotobiol.2011.01.020

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  6 in total

Review 1.  Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?

Authors:  Anine M Crous; Heidi Abrahamse
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

Review 2.  Developing strategies to predict photodynamic therapy outcome: the role of melanoma microenvironment.

Authors:  Renzo Emanuel Vera; María Julia Lamberti; Viviana Alicia Rivarola; Natalia Belén Rumie Vittar
Journal:  Tumour Biol       Date:  2015-09-29

3.  Improved photodynamic efficacy of Zn(II) phthalocyanines via glycerol substitution.

Authors:  Yunni Chin; Siang Hui Lim; Yunus Zorlu; Vefa Ahsen; Lik Voon Kiew; Lip Yong Chung; Fabienne Dumoulin; Hong Boon Lee
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

4.  Specific Targeting of Melanotic Cells with Peptide Ligated Photosensitizers for Photodynamic Therapy.

Authors:  Paul Lorenz Bigliardi; Bhimsen Rout; Aakanksha Pant; Viknish Krishnan-Kutty; Alex N Eberle; Ramasamy Srinivas; Brendan Adrian Burkett; Mei Bigliardi-Qi
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

5.  Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.

Authors:  Haiqin Song; Zhenghao Cai; Juyi Li; Haihua Xiao; Ruogu Qi; Minhua Zheng
Journal:  J Nanobiotechnology       Date:  2022-07-16       Impact factor: 9.429

6.  Photodynamic therapy of melanoma using new, synthetic porphyrins and phthalocyanines as photosensitisers - a comparative study.

Authors:  Ioana Baldea; Rodica-Mariana Ion; Diana Elena Olteanu; Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip
Journal:  Clujul Med       Date:  2015-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.